When can a chest tube (CTT) be removed in a patient with pneumothorax due to pulmonary tuberculosis (PTB) and status post chest tube (CTT) insertion?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Chest tube removal in a patient with pneumothorax due to pulmonary tuberculosis (PTB) who has undergone chest tube thoracostomy (CTT) can typically be considered when there is no air leak for 24 hours, the lung has fully re-expanded on chest X-ray, and drainage has decreased, as suggested by the most recent guidelines 1. When considering the removal of a chest tube in such patients, several factors must be taken into account to ensure the best possible outcome in terms of morbidity, mortality, and quality of life.

Key Considerations for Chest Tube Removal

  • The absence of an air leak for a specified period is crucial, with the exact duration potentially varying based on individual patient factors and clinical guidelines.
  • Full re-expansion of the lung, as confirmed by chest X-ray, is another critical factor indicating that the pneumothorax has resolved and the lung is ready for the chest tube to be removed.
  • The volume of drainage is also an important consideration, with lower volumes suggesting that the risk of complications following chest tube removal may be reduced.

Clinical Stability and Procedure

Before removing the chest tube, it is essential to ensure that the patient is clinically stable, with normal vital signs, adequate pain control, and an improving respiratory status. The procedure for removing the chest tube should be performed at end-expiration or during a Valsalva maneuver to prevent air from entering the pleural space, which could lead to a recurrence of the pneumothorax.

Post-Removal Care

After the chest tube is removed, an occlusive dressing should be applied, and a post-removal chest X-ray should be obtained to confirm that the lung remains expanded. Continuing appropriate anti-tuberculosis therapy is vital throughout this process, as treating the underlying PTB is essential to prevent the recurrence of pneumothorax.

Individualized Decision Making

The timing of chest tube removal ultimately depends on individual patient factors and should be determined by the treating physician based on clinical improvement and resolution of the pneumothorax, considering the latest guidelines and evidence available, such as those from the British Thoracic Society guideline for pleural disease 1.

From the Research

Removal of Chest Tube in Pneumothorax due to Pulmonary Tuberculosis

  • The decision to remove a chest tube (CTT) in a patient with pneumothorax due to pulmonary tuberculosis (PTB) depends on several factors, including the resolution of the pneumothorax and the absence of air leaks 2, 3.
  • According to a study published in The European Respiratory Journal, the mean length of pleural drainage treatment was 12.9 days, and most patients (85%) required only one drainage procedure 2.
  • Another study published in La Tunisie Medicale reported an average duration of chest tube drainage of 23 days in patients with spontaneous pneumothorax secondary to tuberculosis 3.
  • It is essential to ensure that the pneumothorax has resolved and there are no persistent air leaks before removing the chest tube, as persistent air leaks can lead to further complications, such as the need for surgical intervention 2, 3.
  • The treatment of pneumothorax due to PTB typically involves antitubercular chemotherapy, chest drainage, and respiratory physiotherapy, and the removal of the chest tube should be guided by the patient's clinical response to treatment and the resolution of the pneumothorax 2, 3.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Spontaneous pneumothorax and tuberculosis: long-term follow-up.

The European respiratory journal, 2011

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.